Incidence and Risk Factors for Hospitalization-Associated Disability

Universitaire Ziekenhuizen KU Leuven

Status: Completed

Conditions: Hospitalization-associated Disability; Functional Decline; Iatrogenic Disease

Treatments: Procedure: Not applicable (observational design)

Study type: Observational

Funder types: Other

Identifiers

NCT02572999

C22/15/028/01

Details and patient eligibility

About

This prospective cohort study aims to determine the incidence of hospitalization-associated disability and its association with risk factors at the patient level and with care and hospital processes. For this, patients aged 70 years or older admitted for elective valve surgery or elective transcatheter aortic valve implantation or as a result of symptomatic moderate to severe valvular heart disease will be consecutively included from 01 October 2015 to 29 February 2016.

Enrollment: 80 patients

Sex: All

Ages: 70+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Aged 70 years or older
• Admitted for elective heart valve surgery (replacement, repair or combined with CABG) or if admitted for elective transcatheter aortic valve implantation, or if a patient presents with symptomatic moderate to severe valvular heart disease on hospital admission as evidenced by moderate to severe valve regurgitation (≥ 2/4) or aortic valve area ≤ 1cm2 or mitral valve area ≤ 1.5cm2 and if one of the following symptoms is present: heart failure, decreased exercise tolerance, (exertional) dyspnea, (exertional) angina, (exertional) syncope
• Dutch speaking

Exclusion criteria

• Life expectancy less than 6 months
• Expected length of stay less than 48 hours

Trial design

80 participants in 1 patient group

Valvular heart disease

Description:

All patients aged 70 years or older, consecutively admitted for elective heart valve surgery or if admitted for elective transcatheter aortic valve implantation, or if a patient presents with symptomatic moderate to severe valvular heart disease on hospital admission as evidenced by moderate to severe valve regurgitation or stenosis will be included in this cohort. Participants will be observed up to 30 days post-hospital discharge

Treatment:

Procedure: Not applicable (observational design)